← Back to headlines
Analysts Downgrade Myriad Genetics Amid Profitability Concerns
Financial analysts have issued multiple downgrades for Myriad Genetics stock, citing growing doubts about the company’s near-term profitability and financial outlook. The revised ratings reflect broader investor caution regarding the firm’s operational performance.
Sources
Showing 0 of 2 sources
No articles available in your preferred languages.
2 articles available in other languages below.
Barron'sFrench1d ago
Myriad Genetics Stock Gets Double-Downgrade as Profitability Concerns Grow - barrons.com
Myriad Genetics Stock Gets Double-Downgrade as Profitability Concerns Grow barrons.com
Read full article →investing-comFrench1d ago
Piper Sandler cuts Myriad Genetics stock rating on profit concerns
Read full article →Coverage Timeline
First report: investing-com · 1 Sept, 11:24|Full coverage: 2 · 5h|Window: 5h
Left-leaningCenterRight-leaning
